ZNTL
Zentalis Pharmaceuticals, Inc.Company with tickers: ZNTL
CIK
1725160
CUSIP
98943L107
Shares Outstanding
70,931,016
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-02-10 | Vultaggio Vincent | PAO and PFO | Sell | 6,894 |
| 2026-02-09 | EASTLAND JULIA MARIE | Director, CEO & President | Sell | 889 |
| 2026-02-09 | Bruns Ingmar | Chief Medical Officer | Sell | 335 |
| 2026-02-09 | Vultaggio Vincent | PAO and PFO | Sell | 3,379 |
| 2026-02-06 | EASTLAND JULIA MARIE | Director, CEO & President | Sell | 7,866 |
| 2026-02-06 | Bruns Ingmar | Chief Medical Officer | Sell | 2,962 |
| 2026-02-06 | Vultaggio Vincent | PAO and PFO | Sell | 29,951 |
| 2026-02-03 | Vultaggio Vincent | PAO and PFO | Sell | 556 |
| 2026-02-02 | Vultaggio Vincent | PAO and PFO | Sell | 2,540 |
| 2026-01-08 | Vultaggio Vincent | PAO and PFO | Award | 100,000 |
| 2026-01-08 | Bucher James B | EVP and General Counsel | Award | 100,000 |
| 2026-01-08 | Bruns Ingmar | Chief Medical Officer | Award | 365,000 |
| 2026-01-08 | EASTLAND JULIA MARIE | Director, CEO & President | Award | 775,000 |
| 2025-12-31 | WALTERS GROUP | 10% Owner | Buy | 6,459,973 |
| 2025-12-15 | Matrix Capital Management Company, LP | 10% Owner | Sell | 7,500,000 |
| 2025-12-15 | WALTERS GROUP | 10% Owner | Other | 7,050,000 |
| 2025-10-01 | Bucher James B | EVP and General Counsel | Award | 400,000 |
| 2025-09-18 | Bucher James B | EVP and General Counsel | Other | 0 |
| 2025-06-17 | Walker Luke Nathaniel | Director | Award | 57,603 |
| 2025-06-17 | Skvarka Jan | Director | Award | 57,603 |
| 2025-06-17 | Johnson David Michael | Director | Award | 57,603 |
| 2025-06-17 | Kariuki Enoch | Director | Award | 57,603 |
| 2025-06-17 | Myers Scott Dunseth | Director | Award | 57,603 |
| 2025-04-30 | Myers Scott Dunseth | Director | Buy | 21,000 |
| 2025-02-06 | Bruns Ingmar | Chief Medical Officer | Buy | 20,000 |
| 2025-02-03 | Vultaggio Vincent | PAO and PFO | Sell | 2,615 |
| 2025-02-03 | Vultaggio Vincent | PAO and PFO | Award | 158,586 |
| 2025-02-03 | Vultaggio Vincent | PAO and PFO | Award | 35,633 |
| 2025-02-03 | Lackner Mark | Chief Scientific Officer | Award | 124,714 |
| 2025-02-03 | Lackner Mark | Chief Scientific Officer | Award | 335,907 |
| 2025-02-03 | Lackner Mark | Chief Scientific Officer | Sell | 14,368 |
| 2025-02-03 | Paul Andrea | Chief Legal Officer | Award | 934,041 |
| 2025-02-03 | Paul Andrea | Chief Legal Officer | Sell | 13,230 |
| 2025-02-03 | Paul Andrea | Chief Legal Officer | Award | 124,714 |
| 2025-02-03 | Bruns Ingmar | Chief Medical Officer | Award | 16,629 |
| 2025-02-03 | Bruns Ingmar | Chief Medical Officer | Award | 16,629 |
| 2025-02-03 | EASTLAND JULIA MARIE | Director, CEO & President | Award | 59,388 |
| 2025-02-03 | EASTLAND JULIA MARIE | Director, CEO & President | Award | 59,388 |
| 2025-01-31 | Skvarka Jan | Director | Buy | 60,000 |
| 2025-01-31 | Walker Luke Nathaniel | Director | Buy | 14,200 |
| 2025-01-31 | EASTLAND JULIA MARIE | Director, CEO & President | Buy | 28,500 |
| 2025-01-02 | Lackner Mark | Chief Scientific Officer | Sell | 4,411 |
| 2024-12-02 | EASTLAND JULIA MARIE | Director, CEO & President | Award | 3,028,800 |
| 2024-12-02 | Bruns Ingmar | Chief Medical Officer | Award | 712,650 |
| 2024-11-13 | Myers Scott Dunseth | Director | Award | 260,192 |
| 2024-11-13 | Bruns Ingmar | Chief Medical Officer | Other | 0 |
| 2024-11-13 | EASTLAND JULIA MARIE | Director, CEO & President | Other | 0 |
| 2024-11-13 | Myers Scott Dunseth | Director | Other | 0 |
| 2024-10-04 | Vultaggio Vincent | PAO and PFO | Sell | 1,603 |
| 2024-06-21 | Skvarka Jan | Director | Award | 41,581 |
| 2024-06-21 | Kariuki Enoch | Director | Award | 41,581 |
| 2024-06-21 | Johnson David Michael | Director | Award | 48,429 |
| 2024-05-31 | Gallagher Cam | Director, President, Interim CFO | Sell | 9,597 |
| 2024-05-24 | Walker Luke Nathaniel | Director | Award | 72,481 |
| 2024-05-24 | Walker Luke Nathaniel | Director | Other | 0 |
| 2024-05-09 | HAUSMAN DIANA | Director | Sell | 3,356 |
| 2024-04-05 | Vultaggio Vincent | PAO and PFO | Other | 35,458 |
| 2024-04-05 | Vultaggio Vincent | PAO and PFO | Other | 0 |
| 2024-02-12 | Epperly Melissa B, | Director | Sell | 2,573 |
| 2024-02-12 | Gallagher Cam | Director, President, Interim CFO | Sell | 1,173 |
| 2024-02-02 | Gallagher Cam | Director, President, Interim CFO | Sell | 11,552 |
| 2024-02-02 | Epperly Melissa B, | Director | Sell | 8,669 |
| 2024-02-02 | Lackner Mark | Chief Scientific Officer | Sell | 1,585 |
| 2024-02-02 | Paul Andrea | Chief Legal Officer | Sell | 3,310 |
| 2024-02-01 | Gallagher Cam | Director, President, Interim CFO | Award | 192,500 |
| 2024-02-01 | Gallagher Cam | Director, President, Interim CFO | Award | 192,500 |
| 2024-02-01 | Epperly Melissa B, | Director | Award | 75,000 |
| 2024-02-01 | Epperly Melissa B, | Director | Award | 75,000 |
| 2024-02-01 | Blackwell Kimberly | Director | Tax | 20,655 |
| 2024-02-01 | Blackwell Kimberly | Director | Award | 250,000 |
| 2024-02-01 | Blackwell Kimberly | Director | Award | 250,000 |
| 2024-02-01 | HAUSMAN DIANA | Director | Award | 337,500 |
| 2024-02-01 | HAUSMAN DIANA | Director | Award | 337,500 |
| 2024-02-01 | Lackner Mark | Chief Scientific Officer | Award | 141,000 |
| 2024-02-01 | Lackner Mark | Chief Scientific Officer | Award | 141,000 |
| 2024-02-01 | Paul Andrea | Chief Legal Officer | Award | 112,500 |
| 2024-02-01 | Paul Andrea | Chief Legal Officer | Award | 112,500 |
| 2024-01-02 | Lackner Mark | Chief Scientific Officer | Award | 40,000 |
| 2024-01-02 | Lackner Mark | Chief Scientific Officer | Award | 60,000 |
| 2023-12-31 | Lackner Mark | Chief Scientific Officer | Other | 0 |
| 2023-12-31 | Lackner Mark | Chief Scientific Officer | Other | 16,313 |
| 2023-12-20 | Bunker Kevin D. | Chief Scientific Officer | Gift | 24,158 |
| 2023-12-20 | Bunker Kevin D. | Chief Scientific Officer | Other | 15,000 |
| 2023-11-13 | Blackwell Kimberly | Director | Buy | 5,000 |
| 2023-11-10 | Johnson David Michael | Director | Buy | 17,000 |
| 2023-10-04 | Brownstein Carrie | Director | Sell | 8,906 |
| 2023-10-04 | Bunker Kevin D. | Chief Scientific Officer | Sell | 5,085 |
| 2023-10-04 | Bunker Kevin D. | Chief Scientific Officer | Other | 15,000 |
| 2023-10-04 | Epperly Melissa B, | Director | Sell | 4,594 |
| 2023-09-11 | Skvarka Jan | Director | Sell | 5,000 |
| 2023-06-20 | Matrix Capital Management Company, LP | 10% Owner | Buy | 4,760,000 |
| 2023-06-16 | Johnson David Michael | Director | Award | 19,059 |
| 2023-06-16 | Kariuki Enoch | Director | Award | 16,364 |
| 2023-06-16 | Skvarka Jan | Director | Award | 16,364 |
| 2023-05-31 | Gallagher Cam | Director, President, Interim CFO | Sell | 9,242 |
| 2023-05-26 | Bunker Kevin D. | Chief Scientific Officer | Sell | 80,000 |
| 2023-05-26 | Bunker Kevin D. | Chief Scientific Officer | Other | 865,157 |
| 2023-05-08 | HAUSMAN DIANA | Director | Award | 39,732 |
| 2023-05-08 | HAUSMAN DIANA | Director | Other | 0 |
| 2023-03-01 | Roth Iris | Chief Operating Officer | Award | 297,500 |